Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention
Abstract
Activator protein 1 (AP-1) is a key transcription factor in the control of several cellular processes responsible for cell survival proliferation and differentiation. Dysfunctional AP-1 expression and activity are involved in several severe diseases, especially inflammatory disorders and cancer. Therefore, targeting AP-1 has recently emerged as an attractive therapeutic strategy for cancer prevention and therapy. This review summarizes our current understanding of AP-1 biology and function as well as explores and discusses several natural bioactive compounds modulating AP-1-associated signaling pathways for cancer prevention and intervention. Current limitations, challenges, and future directions of research are also critically discussed. (C) 2017 Elsevier Ltd. All rights reserved.
Más información
| Título según WOS: | ID WOS:000435626500037 Not found in local WOS DB |
| Título de la Revista: | PHARMACOLOGICAL RESEARCH |
| Volumen: | 128 |
| Editorial: | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD |
| Fecha de publicación: | 2018 |
| Página de inicio: | 366 |
| Página final: | 375 |
| DOI: |
10.1016/j.phrs.2017.09.014 |
| Notas: | ISI |